<?xml version="1.0" encoding="UTF-8"?>

<StructureDefinition xmlns="http://hl7.org/fhir">
  <id value="SubstanceProtein"/>
  <meta>
    <lastUpdated value="2020-12-31T07:32:20.021+11:00"/>
  </meta>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-category">
    <valueString value="Specialized.Medication Definition"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="trial-use"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-security-category">
    <valueCode value="anonymous"/>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="brr"/>
  </extension>
  <url value="http://hl7.org/fhir/StructureDefinition/SubstanceProtein"/>
  <version value="4.6.0"/>
  <name value="SubstanceProtein"/>
  <status value="draft"/>
  <date value="2020-12-31T07:32:20+11:00"/>
  <publisher value="Health Level Seven International (Biomedical Research and Regulation)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/fhir"/>
    </telecom>
  </contact>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://www.hl7.org/Special/committees/rcrim/index.cfm"/>
    </telecom>
  </contact>
  <description value="A SubstanceProtein is defined as a single unit of a linear amino acid sequence, or a combination of subunits that are either covalently linked or have a defined invariant stoichiometric relationship. This includes all synthetic, recombinant and purified SubstanceProteins of defined sequence, whether the use is therapeutic or prophylactic. This set of elements will be used to describe albumins, coagulation factors, cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes, toxins, toxoids, recombinant vaccines, and immunomodulators."/>
  <fhirVersion value="4.6.0"/>
  <mapping>
    <identity value="w5"/>
    <uri value="http://hl7.org/fhir/fivews"/>
    <name value="FiveWs Pattern Mapping"/>
  </mapping>
  <mapping>
    <identity value="rim"/>
    <uri value="http://hl7.org/v3"/>
    <name value="RIM Mapping"/>
  </mapping>
  <kind value="resource"/>
  <abstract value="false"/>
  <type value="SubstanceProtein"/>
  <baseDefinition value="http://hl7.org/fhir/StructureDefinition/DomainResource"/>
  <derivation value="specialization"/>
  <differential>
    <element id="SubstanceProtein">
      <extension url="http://hl7.org/fhir/build/StructureDefinition/svg">
        <valueCode value="100,0"/>
      </extension>
      <path value="SubstanceProtein"/>
      <short value="A SubstanceProtein is defined as a single unit of a linear amino acid sequence, or a combination of subunits that are either covalently linked or have a defined invariant stoichiometric relationship. This includes all synthetic, recombinant and purified SubstanceProteins of defined sequence, whether the use is therapeutic or prophylactic. This set of elements will be used to describe albumins, coagulation factors, cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes, toxins, toxoids, recombinant vaccines, and immunomodulators"/>
      <definition value="A SubstanceProtein is defined as a single unit of a linear amino acid sequence, or a combination of subunits that are either covalently linked or have a defined invariant stoichiometric relationship. This includes all synthetic, recombinant and purified SubstanceProteins of defined sequence, whether the use is therapeutic or prophylactic. This set of elements will be used to describe albumins, coagulation factors, cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes, toxins, toxoids, recombinant vaccines, and immunomodulators."/>
      <min value="0"/>
      <max value="*"/>
      <mapping>
        <identity value="w5"/>
        <map value="administrative.medication"/>
      </mapping>
    </element>
    <element id="SubstanceProtein.sequenceType">
      <path value="SubstanceProtein.sequenceType"/>
      <short value="The SubstanceProtein descriptive elements will only be used when a complete or partial amino acid sequence is available or derivable from a nucleic acid sequence"/>
      <definition value="The SubstanceProtein descriptive elements will only be used when a complete or partial amino acid sequence is available or derivable from a nucleic acid sequence."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="CodeableConcept"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.numberOfSubunits">
      <path value="SubstanceProtein.numberOfSubunits"/>
      <short value="Number of linear sequences of amino acids linked through peptide bonds. The number of subunits constituting the SubstanceProtein shall be described. It is possible that the number of subunits can be variable"/>
      <definition value="Number of linear sequences of amino acids linked through peptide bonds. The number of subunits constituting the SubstanceProtein shall be described. It is possible that the number of subunits can be variable."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="integer"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.disulfideLinkage">
      <path value="SubstanceProtein.disulfideLinkage"/>
      <short value="The disulphide bond between two cysteine residues either on the same subunit or on two different subunits shall be described. The position of the disulfide bonds in the SubstanceProtein shall be listed in increasing order of subunit number and position within subunit followed by the abbreviation of the amino acids involved. The disulfide linkage positions shall actually contain the amino acid Cysteine at the respective positions"/>
      <definition value="The disulphide bond between two cysteine residues either on the same subunit or on two different subunits shall be described. The position of the disulfide bonds in the SubstanceProtein shall be listed in increasing order of subunit number and position within subunit followed by the abbreviation of the amino acids involved. The disulfide linkage positions shall actually contain the amino acid Cysteine at the respective positions."/>
      <min value="0"/>
      <max value="*"/>
      <type>
        <code value="string"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit">
      <extension url="http://hl7.org/fhir/build/StructureDefinition/svg">
        <valueCode value="200,150"/>
      </extension>
      <path value="SubstanceProtein.subunit"/>
      <short value="This subclause refers to the description of each subunit constituting the SubstanceProtein. A subunit is a linear sequence of amino acids linked through peptide bonds. The Subunit information shall be provided when the finished SubstanceProtein is a complex of multiple sequences; subunits are not used to delineate domains within a single sequence. Subunits are listed in order of decreasing length; sequences of the same length will be ordered by decreasing molecular weight; subunits that have identical sequences will be repeated multiple times"/>
      <definition value="This subclause refers to the description of each subunit constituting the SubstanceProtein. A subunit is a linear sequence of amino acids linked through peptide bonds. The Subunit information shall be provided when the finished SubstanceProtein is a complex of multiple sequences; subunits are not used to delineate domains within a single sequence. Subunits are listed in order of decreasing length; sequences of the same length will be ordered by decreasing molecular weight; subunits that have identical sequences will be repeated multiple times."/>
      <min value="0"/>
      <max value="*"/>
      <type>
        <code value="BackboneElement"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.subunit">
      <path value="SubstanceProtein.subunit.subunit"/>
      <short value="Index of primary sequences of amino acids linked through peptide bonds in order of decreasing length. Sequences of the same length will be ordered by molecular weight. Subunits that have identical sequences will be repeated and have sequential subscripts"/>
      <definition value="Index of primary sequences of amino acids linked through peptide bonds in order of decreasing length. Sequences of the same length will be ordered by molecular weight. Subunits that have identical sequences will be repeated and have sequential subscripts."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="integer"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.sequence">
      <path value="SubstanceProtein.subunit.sequence"/>
      <short value="The sequence information shall be provided enumerating the amino acids from N- to C-terminal end using standard single-letter amino acid codes. Uppercase shall be used for L-amino acids and lowercase for D-amino acids. Transcribed SubstanceProteins will always be described using the translated sequence; for synthetic peptide containing amino acids that are not represented with a single letter code an X should be used within the sequence. The modified amino acids will be distinguished by their position in the sequence"/>
      <definition value="The sequence information shall be provided enumerating the amino acids from N- to C-terminal end using standard single-letter amino acid codes. Uppercase shall be used for L-amino acids and lowercase for D-amino acids. Transcribed SubstanceProteins will always be described using the translated sequence; for synthetic peptide containing amino acids that are not represented with a single letter code an X should be used within the sequence. The modified amino acids will be distinguished by their position in the sequence."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="string"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.length">
      <path value="SubstanceProtein.subunit.length"/>
      <short value="Length of linear sequences of amino acids contained in the subunit"/>
      <definition value="Length of linear sequences of amino acids contained in the subunit."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="integer"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.sequenceAttachment">
      <path value="SubstanceProtein.subunit.sequenceAttachment"/>
      <short value="The sequence information shall be provided enumerating the amino acids from N- to C-terminal end using standard single-letter amino acid codes. Uppercase shall be used for L-amino acids and lowercase for D-amino acids. Transcribed SubstanceProteins will always be described using the translated sequence; for synthetic peptide containing amino acids that are not represented with a single letter code an X should be used within the sequence. The modified amino acids will be distinguished by their position in the sequence"/>
      <definition value="The sequence information shall be provided enumerating the amino acids from N- to C-terminal end using standard single-letter amino acid codes. Uppercase shall be used for L-amino acids and lowercase for D-amino acids. Transcribed SubstanceProteins will always be described using the translated sequence; for synthetic peptide containing amino acids that are not represented with a single letter code an X should be used within the sequence. The modified amino acids will be distinguished by their position in the sequence."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="Attachment"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.nTerminalModificationId">
      <path value="SubstanceProtein.subunit.nTerminalModificationId"/>
      <short value="Unique identifier for molecular fragment modification based on the ISO 11238 Substance ID"/>
      <definition value="Unique identifier for molecular fragment modification based on the ISO 11238 Substance ID."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="Identifier"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.nTerminalModification">
      <path value="SubstanceProtein.subunit.nTerminalModification"/>
      <short value="The name of the fragment modified at the N-terminal of the SubstanceProtein shall be specified"/>
      <definition value="The name of the fragment modified at the N-terminal of the SubstanceProtein shall be specified."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="string"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.cTerminalModificationId">
      <path value="SubstanceProtein.subunit.cTerminalModificationId"/>
      <short value="Unique identifier for molecular fragment modification based on the ISO 11238 Substance ID"/>
      <definition value="Unique identifier for molecular fragment modification based on the ISO 11238 Substance ID."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="Identifier"/>
      </type>
      <isSummary value="true"/>
    </element>
    <element id="SubstanceProtein.subunit.cTerminalModification">
      <path value="SubstanceProtein.subunit.cTerminalModification"/>
      <short value="The modification at the C-terminal shall be specified"/>
      <definition value="The modification at the C-terminal shall be specified."/>
      <min value="0"/>
      <max value="1"/>
      <type>
        <code value="string"/>
      </type>
      <isSummary value="true"/>
    </element>
  </differential>
</StructureDefinition>